reference/23604741

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23604741

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	222
issn	0028-4793 1533-4406
issueIdentifier	3
pageRange	211-222
publicationName	The New England journal of medicine
startingPage	211
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f1403f137aeb517259c0061c08a34937 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f7f7d1bf47b6bfffddfb447a9725a95f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d2cd633e9588584eccbb0711847356a4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_88500c28be8c00d5a3d24768662718d9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0af585b4e4572d71a2484156e749bf47 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7ce659d317d2f06ae96ed7f551bbefdb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f949483b1c0242981fdde04b56a37494 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9099dd9871cbfca273cf47c81ff1a1bb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_83e72b3b379fd4dc78e5306fcd6efd12 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7e27973d14f1cbfc6f99fa9f7f797dd7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae71384b063b1f65720193cd1514a46b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_24c44cb306ce0f70a4fd067a1faa8193 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a94a0a78a0d59aeb0f88d85d7d1aa23c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e432d4dac62c09cfc9274c26955b611d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0285eac192ade9877529bfee6a7a540c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b9ba000a2d94c9b960d2037e0e3eebb7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0734c764f767ca431c3bc5113affc9c9
bibliographicCitation	Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med. 2016 Jan 21;374(3):211–22. PMID: 26789870; PMCID: PMC4784450.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_676cfdeb43bce40af1e00f50737928ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ea6d0bce31e686b04b2c69bd383013d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0afbadaaf5661ccc0c2e273ed41fc295 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b3dab5e1f0144cd69c1b903dcb007de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32a28f292a64da80a87c9dbf0056c0e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe892a52a6f912107c916a3be69fe9c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47b645d7d8d67d991e360f09bc480a3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d927c4e62c422a43456ed328f55c8fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_771dedaf877a5306cdd56811853ea4e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0ecc9f262101aa8b358dd4cccc37563 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dab917d2db352295aa1d5e1e38d8a608 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f76f28322c3fc8e34739711ded47ada4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_389b75f68916a4d1a740f459319b96ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8973e1c81c7a925ea2a516835f2bff6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcea68e42477796a73e621e70fef8632 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c76bba223308178bf302dda2b7ed6781 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e50ff9091861b745e619669c311f43e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88b3c4747445ef9d5546312d5676c6b7
date	2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/26789870 https://pubmed.ncbi.nlm.nih.gov/PMC4784450 https://doi.org/10.1056/nejmoa1506597
isPartOf	https://portal.issn.org/resource/ISSN/0028-4793 https://portal.issn.org/resource/ISSN/1533-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
discusses	http://id.nlm.nih.gov/mesh/M000615244 http://id.nlm.nih.gov/mesh/M0027627 http://id.nlm.nih.gov/mesh/M0471680 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003110Q000235 http://id.nlm.nih.gov/mesh/D015870 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D018398Q000378 http://id.nlm.nih.gov/mesh/D014408Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020411 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D000071616 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D030541 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D003110Q000473 http://id.nlm.nih.gov/mesh/D003110Q000378 http://id.nlm.nih.gov/mesh/D012333Q000378 http://id.nlm.nih.gov/mesh/D003110Q000188 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D018398Q000235 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D019295 http://id.nlm.nih.gov/mesh/D000704
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47e1ad3de5322c7cdeb890f8fcc292a3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1045

Total number of triples: 90.